S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Lahaina residents worry a rebuilt Maui town could slip into the hands of affluent outsiders
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Could This Tiny, sub-$5 Stock Be the Biggest AI Opportunity of 2023? (Ad)
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Lahaina residents worry a rebuilt Maui town could slip into the hands of affluent outsiders
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Could This Tiny, sub-$5 Stock Be the Biggest AI Opportunity of 2023? (Ad)
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Lahaina residents worry a rebuilt Maui town could slip into the hands of affluent outsiders
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Could This Tiny, sub-$5 Stock Be the Biggest AI Opportunity of 2023? (Ad)
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Lahaina residents worry a rebuilt Maui town could slip into the hands of affluent outsiders
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Could This Tiny, sub-$5 Stock Be the Biggest AI Opportunity of 2023? (Ad)
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives

The Trader's Guide to Equities Research

Welcome to the Trader’s Guide for Equities Research.

There are more than 7,000 publicly traded companies across the globe, which are covered by more than 400 different brokerages. Each trading day, brokerages collectively issue more than 500 research notes on any number of stocks. Our daily newsletter, MarketBeat Daily Ratings, provides nearly comprehensive coverage on equities research changes on a daily basis.

The number one question we receive from our subscribers is, “How do I make trading decisions based on the information in your daily reports?” The Trader’s Guide to Equities Research is our effort to answer that question.

In The Trader’s Guide to Equities Research, you will:
  • Take in the basics of the world of equities research.
  • Learn how to evaluate a stock based on what equities research analysts are saying about it.
  • Receive a list of which brokerages offer the most accurate twelve month price targets.
  • Learn which brokerages recommendations have historically resulted in the highest 7 day, 30 day and 365 day ROI.
  • Get the ten most recent recommendations from each brokerage listed on our Top Brokerages list.
  • Acquire a list of which companies have received the highest average ratings from equities research analysts.
  • Learn the ratings systems used by more than 150 of the top equities research firms.
  • Get access to dozens of additional resources that will help broaden your knowledge of equities research.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

My Account -